Modular Medical, Inc.
MODDHealthcareNASDAQMedical Devices · Last scanned Sep 7, 2026
Scan Results
Daily timeframeModular Medical, Inc. operates as a medical device company. The company carries a $30.0M market cap, placing it firmly in the micro-cap category. The company focuses on the design, development, and commercialization of insulin pumps.
Market Cap
$30.0M
Beta
0.24
P/E (TTM)
—
P/E (Fwd)
-7.22
EPS (TTM)
$-9.85
EPS (Fwd)
$-0.51
ROE
-247.9%
ROA
-129.1%
Cash
$3.9M
Total Debt
$278,000
Free CF
-$18.0M
52W Change
-83.0%
Annual Financials
Cash vs Debt
Where MODD stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, MODD finished 37.43% below its 150-day moving average ($5.53) and 52.73% below its 200-day moving average ($7.32). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MODD overbought or oversold?
At the September 3, 2026 close, MODD's RSI(14) was 71.5, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $3.9M in cash and $278K in debt, MODD maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$18.0M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -247.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
With a beta below 0.7, Modular Medical, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. With cash comfortably exceeding debt, MODD has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Modular Medical, Inc. and its sector.